Skip to content

Achieve Life Sciences ACHV Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies

AvePoint, Inc. logo
AvePoint, Inc.AVPT
$1.07M+10.2%
Trilogy Metals logo
Trilogy MetalsTMQ
$759.5K+35.2%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$19.1M+144%
Cinemark Holdings logo
Cinemark HoldingsCNK
$700K-98.0%
Nabors Industries logo
Nabors IndustriesNBR
$5.38M+113%
ATN International logo
ATN InternationalATNI
$2M+19.1%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
Achieve Life Sciences (ACHV) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of $2.72M in Q4 2025.
How has Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount increased by 27.4% year-over-year, from $2.13M to $2.72M.
What is the long-term trend for Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
Over 4 years (2021 to 2025), Achieve Life Sciences's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 9.5% compound annual growth rate (CAGR), from $7.54M to $10.86M.
What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
This represents the dollar amount of adjustments made to the valuation allowance for deferred tax assets during the reporting period. It indicates management's assessment of the recoverability of tax assets based on future profit expectations. Significant changes often signal shifts in the company's long-term financial outlook.